High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study

Arteriosclerosis, Thrombosis, and Vascular Biology
Bela F AsztalosErnst J Schaefer

Abstract

High-density lipoprotein (HDL) is a heterogeneous lipoprotein class and there is no consensus on the value of HDL subspecies in coronary heart disease (CHD) risk assessment. We tested the hypothesis whether specific HDL subpopulations are significantly associated with CHD-prevalence. ApoA-I concentrations (mg/dL) in HDL subpopulations were quantitatively determined by native 2d gel electrophoresis, immunoblotting, and image analysis in male participants in the Framingham Offspring Study (FOS). CHD cases (n=169) had higher prebeta-1 and alpha-3 particle and lower alpha-1, prealpha-3, and prealpha-1 particle levels than either all (n=1277) or HDL cholesterol-matched (n=358) controls. alpha-1 and prealpha-3 levels had an inverse association, whereas alpha-3 and prealpha-1 particle levels had a positive association with CHD prevalence after adjusting the data for established CHD risk factors. Standardized logit coefficients indicated that alpha-1 HDL was most significantly associated with CHD prevalence. Moreover, each mg/dL increase in alpha-1 particle level decreased odds of CHD by 26% (P<0.0001), whereas each mg/dL increase in HDL cholesterol decreased odds of CHD by 2% in a model including all established CHD risk factors. Spec...Continue Reading

References

Sep 1, 1979·American Journal of Epidemiology·W B KannelW P Castelli
Jun 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·H J ParraG Luc
Aug 8, 1991·The New England Journal of Medicine·M J StampferC H Hennekens
May 1, 1990·Electrophoresis·R F JohnstonD L Barker
Nov 1, 1987·Atherosclerosis·P PuchoisJ C Fruchart
Dec 1, 1994·Current Opinion in Lipidology·A von EckardsteinG Assmann
Aug 4, 1999·Nature Genetics·S G Young, C J Fielding
Oct 5, 2002·Journal of Lipid Research·Bela F AsztalosErnst J Schaefer
Mar 15, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Bela F AsztalosErnst J Schaefer
Nov 6, 2003·JAMA : the Journal of the American Medical Association·Steven E NissenRichard Kerensky
Jun 24, 2004·Journal of Lipid Research·Nancy R WebbFrederick C de Beer
Jun 24, 2004·Journal of Lipid Research·Patricia G YanceyGeorge H Rothblat

❮ Previous
Next ❯

Citations

Jul 12, 2008·Clinical and Experimental Medicine·Aleksandra ZeljkovicDimitra Kalimanovska-Ostric
Oct 28, 2009·Cardiovascular Drugs and Therapy·Mariann HarangiGyörgy Paragh
Aug 12, 2006·Current Atherosclerosis Reports·Benjamin J AnsellAlan M Fogelman
Feb 4, 2006·Current Atherosclerosis Reports·Ernst J Schaefer, Bela F Asztalos
Mar 21, 2013·Current Atherosclerosis Reports·Russell M MedfordMargaret K Offermann
Aug 28, 2012·Advanced Drug Delivery Reviews·Marina G DamianoC Shad Thaxton
Jun 7, 2005·Atherosclerosis·Bela F AsztalosChristine Wanke
Aug 26, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Ernst J Schaefer, Bela F Asztalos
Dec 14, 2011·Human Molecular Genetics·Ann-Kristin PetersenGabi Kastenmüller
May 3, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Michele L Mietus-SnyderBruce N Ames
Oct 7, 2006·Menopause : the Journal of the North American Menopause Society·Kelley K PetteeLewis H Kuller
May 14, 2005·Current Opinion in Lipidology·W Sean Davidson, R A Gangani D Silva
May 9, 2006·Current Opinion in Lipidology·Larbi KrimbouJacques Genest
Jul 13, 2006·Current Opinion in Lipidology·Ernst J Schaefer, Bela F Asztalos
Jun 4, 2008·Current Opinion in Cardiology·Matilda FlorentinDimitri P Mikhailidis
Jun 10, 2010·Current Opinion in Lipidology·Ronald M Krauss
May 4, 2011·Current Opinion in Lipidology·Bela F AsztalosErnst J Schaefer
Apr 21, 2012·Current Opinion in Lipidology·John P Kane, Mary J Malloy
Mar 23, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Xin-Min LiStanley L Hazen
Mar 3, 2007·The Journal of Clinical Investigation·Muredach P Reilly, Alan R Tall
Jul 20, 2011·Lipids in Health and Disease·Krista A VaradyCynthia M Kroeger
May 5, 2012·Journal of Lipid Research·Peter J GilliesJohn P Vanden Heuvel
Jul 16, 2010·Journal of Lipid Research·Bela F AsztalosPeter J Havel
Apr 8, 2010·Journal of Lipid Research·Menno VergeerJan Albert Kuivenhoven
Sep 11, 2012·The Journal of Clinical Endocrinology and Metabolism·Lars BerglundUNKNOWN Endocrine society
Aug 8, 2012·PloS One·Simone TalensDingeman C Rijken
Sep 5, 2009·Clinical Chemistry and Laboratory Medicine : CCLM·Ya-Hong MaJin-Kui Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.